This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | MicrobiomeTrials
← Back to trials NCT03516617
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2018-09-10Est. Completion: 2028-11-11
Enrollment target: 120 participantsLocations Mayo Clinic in Arizona, Scottsdale, Arizona, United States Mayo Clinic in Florida, Jacksonville, Florida, United States Mayo Clinic in Rochester, Rochester, Minnesota, United States Other microbiome trials you might be interested in B-All Acute Lymphoblastic Leukemia
Background:
B-cell acute lymphoblastic leukemia (B-ALL) is a type of blood cancer. Some people with B-ALL have a gene m…
Bethesda, United States Est. completion Jun 30, 2030
Malignancy, Hematologic Neoplasms, Hematologic Neoplasms, Hematopoietic Blood Cancer Hematological Neoplasms Hematopoietic Malignancies
Dysmyelopoietic Syndromes
Hematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United States Est. completion Apr 30, 2029
Waldenstrom Macroglobulinemia Lymphoplasmacytic Lymphoma Monoclonal B-Cell Lymphocytosis Small Lymphocytic Lymphoma CLL (Chronic Lymphocytic Leukemia)
Background
The development of new technologies now allow scientists to investigate the molecular basis and clinical man…
Bethesda, United States